2026-04-13T01:57:56Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4556572026-03-21T03:21:56Zcom_2072_98col_2072_378192

Inpatient Hyperglycemia Management and COVID-19 Bellido, Virginia Pérez Pérez, Antonio Universitat Autònoma de Barcelona COVID-19 Diabetes Hospitalized Hyperglycemia Inpatient Insulin therapy SARS-CoV-2 Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been associated with worse outcomes, so it is mandatory to implement effective glycemic control treatment approaches for inpatients with COVID-19. The shortage of personal protective equipment, the need to prevent staff exposure, or the fact that many of the healthcare professionals might be relatively unfamiliar with the management of hyperglycemia may lead to worse glycemic control and, consequently, a worse prognosis. In order to reduce these barriers, we intend to adapt established recommendations to manage hyperglycemia during this pandemic in critical and noncritical care settings. 2020 Article de revisió Article https://ddd.uab.cat/record/238674 urn:10.1007/s13300-020-00966-z urn:oai:ddd.uab.cat:238674 urn:articleid:18696961p1 urn:pmcid:PMC7718834 urn:pmc-uid:7718834 urn:pmid:33278017 urn:oai:pubmedcentral.nih.gov:7718834 eng Diabetes Therapy ; december 2020, p. 1-12 open access Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. https://creativecommons.org/licenses/by-nc/4.0/ application/pdf